Professional Posters

(4-001) Impact of Par Adjustments on Inventory Turnover Ratios at an Ambulatory Infusion Center

(4-002) Implementation of Centralized Product Defect Reporting for Cost Recovery Across Campuses

(4-003) Planning and Relocation of the Pharmacy of a Mother-child University Health Center

(4-004) Survey of Hospital Pharmacy Practice in Canada – 1985-86 to 2020-21

(4-005) Correction of Warfarin Coagulopathy for Non-bleeding Patients in the Outpatient Setting at an Ambulatory Care Organization: Application of Vitamin K Guidance

(4-006) Patient Satisfaction with Point of Care Testing (POCT) for Hemoglobin a1c (HbA1c) at an Academic Medical Center Serving a Rural Population

(4-007) Characterization of the New Orleans Syringe Access Program (NOSAP) Participants During the Initial Months of the Coronavirus Disease 2019 (COVID-19) Naloxone Education and Distribution Services

(4-008) Financial Reimbursement and Productivity Metrics for Pharmacist-led Chronic Care Management Services in Rural Practice Settings

(4-009) Glycemic Impact of Janus Kinase Inhibitors in Diabetic Patients with Immune-mediated Rheumatic Diseases

(4-010) Implementation and Outcomes of a Collaborative Drug Therapy Management Program in a Large Public Health Care System in the United States

(4-011) Patients Who Require Invasive Procedures While Receiving P2Y12 Inhibitors Incur Greater Healthcare Resource Utilization and Costs

(4-012) Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-based Outcomes

(4-013) Evaluation of Direct Oral Anticoagulant Use Following Surgical Bioprosthetic Valve Replacement

(4-014) Real-world Risk of Medullary Thyroid Carcinoma with GLP-1 Receptor Agonist Use: A Review

(4-015) Incidence of Alteplase Utilization for Central Venous Access De-clotting in Patients with Active COVID-19

(4-016) Does Focused Education on the Use of Proton Pump Inhibitors (PPIs) Reduce the Incidence of Acute Upper Gastrointestinal Bleeding (aUGIB) in Patients on Antithrombotic Therapy?

(4-017) Reducing Inpatient Intravenous Iron Use in a Community Hospital

(4-018) Application of a Common Bioassay to Measure Deactivation of Beta-lactam Antibiotics

(4-020) Establishing a Rifaximin Criteria for Use Protocol for Hepatic Encephalopathy

(4-021) Switching to the Most Cost Effective Infliximab in a County Health System

(4-022) Interventions to Improve Methylprednisolone Injection Use in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

(4-023) High Dose Epoetin Alpha in Jehovah’s Witness Patients with Critically Low Hemoglobin Levels

(4-024) Targeted Prescriber and Pharmacist Education for Use of 4-factor PCC in Reversal of Anticoagulation in a Community Hospital

(4-025) Clinical Management of Acute Agitation in Patients with Schizophrenia or Bipolar Disorder in Emergency Departments in the United States – a Retrospective Chart Review

(4-026) Climate Change and Environmental Sustainability Actions of the Pharmaceutical Industry

(4-028) Analysis of Factors Affecting Medication Adherence of Geriatric Outpatients Using the Self-reported Questionnaire

(4-029) Hospital at Home: Evidence to Support the Use of a Home Infusion Pharmacy

(4-030) Collaboration Between a Family Medicine Clinic and Specialty Pharmacy to Administer Vaccines Under Medicare Part D During Home Based Primary Care Visits

(4-032) Efficacy and Safety of Investigational Microbiota-based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection from 5 Prospective Clinical Studies: An Update

(4-033) Assessing awareness and Implementation of Herpes Zoster Vaccine Recommendations by Subspecialists in the United States

(4-034) Implementation of a Restricted Antimicrobial Review Process Within a Long-term Acute Care Hospital

(4-035) Clostridioides Difficile: A Recurrent Infection with Broad Economic Consequences for US Hospitals

(4-036) Impact of a Ceftolozane/tazobactam Shortage in a Long-term Acute Care Hospital System

(4-037) Synergistic Activity Evaluation of Aztreonam in Combination with Ceftazidime-avibactam for Treatment of Resistant Stenotrophomonas Maltophilia in Patients with Cystic Fibrosis using a One-compartment Pharmacokinetic Model

(4-038) Development of Best Practices for Smart Pump Drug Library Pertaining to Neonatal and Infant Continuous Infusions

(4-039) Use of an Order Set to Promote Institutional Change in the Standard Monitoring Assay for Intravenous Heparin Infusion at an Academic Affiliated Health System

(4-040) Exploratory Study on Effect of Repackaging Intravenous Cetirizine Hydrochloride Solution into Syringes on Drug Stability and Microbial Challenge Hold Time

(4-041) Extended Dating of IV Bags Utilizing Low Density Polyethylene Overwrap

(4-042) Evaluating the Use of Blinatumomab Use in a Lebanese Tertiary Care Teaching Hospital

(4-043) The Efficacy and Safety of gp2013-rituximab: A Rituximab Biosimilar in a Tertiary Care Hospital in Lebanon

(4-044) Biosimilar Uptake and Cost Savings Analysis Before and After Implementation of a Pharmacist-driven Substitution Program Within a National Community Oncology Network

(4-045) Evaluation of a Fixed-dose Rasburicase Protocol for Treatment of Hyperuricemia at a Community Medical Center

(4-046) Budget Impact Analysis and Cost Savings of Trastuzumab Biosimilar for the Treatment of Breast Cancer at a Tertiary Cancer Center in the United Arab Emirates

(4-047) Impact of a Pharmacy Diversion Detection Program for Controlled Substance Use in Procedural Areas

(4-048) Opioid-free Recovery After Inguinal Hernia Repair with Bupivacaine and Meloxicam Extended Release Solution as the Foundation of a Multimodal Analgesia Regimen in a Real-world Setting

(4-049) Safely and Effectively Utilizing Opioid Pain Medications in Patients Taking Buprenorphine

(4-051) Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared to Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Indirect Treatment Comparison Methods

(4-052) Systematized Review of the Effect of Posture on Drug Pharmacokinetics: Implications for Clinicians and Clinician-scientists in Drug Development

(4-054) Transition of a Pharmacy Compounding Compliance Platform in a Health System: A Descriptive Journey of Sterile, Non-sterile and Unit Inspection Module Implementation

(4-055) Implementation of Reformatted Titration Orders to Comply with Joint Commission’s Medication Management (MM) Chapter MM.04.01.01

(4-057) Development and Accreditation of a Pharmacy Technician Training Program Within an Academic Healthcare System

(4-058) Mentoring Program for Hospital Pharmacists Involved in Pharmaceutical Management: Assessment of the First Cohort

(4-059) Developing a Virtual Formulary Education Program for Fifth-year Pharmacy Students During an Experiential Hospital Practice Training in an Academic Teaching Hospital in Japan

(4-061) Impact of Latent Tuberculosis Treatment and Psychiatric Medication Interactions in a Long-term Psychiatric Facility

(4-062) Evaluation of Door-to-needle Times for Intravenous Tissue Plasminogen Activator Before and After the Implementation of an Updated Interdisciplinary Code Stroke Process

(4-063) Impact of a Pharmacist-led Transgender Men Health Education Group on Gender-affirming Hormone Therapy and Mental Health Disparities Among Veterans

(4-064) Development and Implementation of a Multimodal Propofol Storage Security Plan at a Large Health System

(4-065) Implementation of Outpatient COVID-19 Therapeutic Prophylaxis, and Treatments at a Mid-size Community Hospital

(4-066) Analysis of Unpredictable Adverse Drug Reaction in Elderly Patients and Drug Assessment

(4-067) Topical Application of a Vancomycin Paste for Hemostasis During Cardiothoracic Surgery: A Safety Assessment

(4-068) Evaluation a Tetanus Immunization Screening Program Implementation in the Emergency Room Department of a Rural Medical Center

(4-069) Naloxone & Opioid Overdose Terminology Preferences Among Rural Caregivers: Differences by Race

(4-070) What Role Do Pharmacists Have in Caring for Patients with Chronic Conditions? Perceptions of Patients with Cardiovascular Disease and Inflammatory Bowel Disease

(4-071) Management of Patients with Multiple Sclerosis Within Health-system Specialty Pharmacies: Patient Reported Outcomes

(4-072) Photoinitiators Including Injection Solution Induce Breast Tumor Growth in Mouse Xenografts with MCF-7 Breast Cancer Cells

(4-073) Evaluation of Perceived Stress and Lifestyle Choices Among U.S. Pharmacy Students at the Beginning of the COVID-19 Pandemic

(4-074) Pharmacy Integration into the Fertility Service Line: University Hospitals Specialty Pharmacy

(8-068) “Meeting DSCSA Compliance Requirements and Creating Strategic Value – One Health System’s Journey”

(8-071) National Strategies to Optimize Taiwan's Drug Supply Chain and Mitigate Drug Shortages Amid COVID-19 Pandemic

(8-072) Two Year Retrospective Comparison of COVID-19 Cases and Drug Expenditure Trends at Five Community Hospitals

(8-073) The Impact of an Intervention on Patients at Risk of Becoming Adherence Outliers Within an Ambulatory Care Pharmacy

(8-074) Impact of an Inflammatory Bowel Disease Pharmacist Program in an Outpatient Clinic

(8-075) Evaluating Ibandronate Prescriptions and Targeting Recommendations for Broad-spectrum Bisphosphonates (IbanBSBPs)

(8-076) Real-world Evidence on Effectiveness, Drug Persistence and Safety of Cycling Janus Kinase Inhibitors in Rheumatoid Arthritis

(8-077) Evaluation of Pharmacist Co-management of Gender Affirming Hormone Therapy in an Endocrinology Clinic (Access-GAHT)

(8-078) Role of Continuous Glucose Monitoring in the Management of Type II Diabetes Mellitus Patients: A Retrospective Review

(8-079) Role of Dopamine D2 Receptor Agonist Prolactin Inhibitor Bromocriptine in Management of Cardiogenic Shock Developed During Childbirth Secondary to Acute Peripartum Cardiomyopathy (PPCM). Case Report

(8-081) Evaluation of High Dose Recombinant Factor Viia for Perioperative Bleeding in Cardiac Surgery Patients

(8-082) The Impact of the Senior Savings Model (SSM) on Medicare Patients for Key Outcomes Related to Insulin Utilization

(8-084) Perception of Pharmacist’s Role in Optimizing Kidney Health in Patients with Chronic Kidney Disease

(8-085) Medication Use Evaluation, Education, and Pharmacist Follow up for Improvement in a Clinical Pharmacy Program at a Rural Medical Center

(8-086) Reduction of COPD Readmissions in an Acute Care Hospital After Implementation of a Transitions of Care Pharmacy Service

(8-087) Evaluation of Pharmacist Managed Basal-bolus Insulin Dosing in Comparison to Physician Glucose Management in a Community Hospital

(8-088) Ceftriaxone-associated Cryptococcoid Sweet Syndrome: A Case Report

(8-089) Rabeprazole Reverses Pantoprazole/esomeprazole Related ALT/AST Elevating in a HCV Infected Patient

(8-090) Once-daily Crisaborole as Long-term Maintenance Treatment to Reduce the Incidence of Flares in Patients with Mild-to-moderate Atopic Dermatitis: A 52-week Clinical Trial

(8-091) Multiple Switching Between the Biosimilar Adalimumab PF-06410293 and High Concentration Reference Adalimumab in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis

(8-092) Evaluation of the Timing of Using Direct Oral Anticoagulants After Ischemic Stroke for Patients with Atrial Fibrillation

(8-093) Pharmacist-provided Tobacco Treatment Services: Implementation for Reimbursement and Sustainability

(8-094) Drug Take Back Days as Part of University Sustainability Initiatives

(8-095) Evaluation of Use of Proton Pump Inhibitors in Community Pharmacies in Different Regions of Lebanon

(8-096) Assessment of Infliximab Use in Hospitalized Patients

(8-097) Pharmacoeconomic and Effectiveness Analysis of the Switching from Prophylactic VIII Factor Concentrates to Emicizumab in Pediatric Hemophilia a Patients in a Tertiary Care Hospital

(8-098) Evaluation of Sugammadex and Neostigmine Use in Neuromuscular Blockade Reversal in the Perioperative Setting at an Academic Medical Center

(8-099) Drug Use Evaluation of Sodium Polystyrene Sulfonate in Patients with Hyperkalemia

(8-102) Accuracy and Reproducibility of Small Volume Injections from Prefilled “code Cart” Syringes Compared to Standard Polypropylene Syringes

(8-103) Mortality Risk and Long-term Complications Associated with Catheter-Related Bloodstream Infections (CRBSIs)

(8-104) Impact of Electronic Health Record Prescribing Guidance on Carbapenem Usage

(8-105) Evaluation of Antibiotic Prescribing Practices upon Hospital Discharge

(8-106) Utilization of Methicillin-resistant Staphylococcus aureus Nasal Swab Polymerase Chain Reaction Assay or Culture to De-escalate Empiric Vancomycin or Linezolid for the Treatment of Pneumonia

(8-107) Monoclonal Antibodies May Reduce Return Visits to the Emergency Department and Hospital Admissions for sars-cov-2

(8-108) Efficacy Data from ECOSPOR III: A Phase 3, Double-blind, Placebo-controlled, Randomized Trial of SER-109, an Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection

(8-109) Tenofovir Disoproxil Fumarate Switching to Tenofovir Alafenamide for Three Years Resulted Hepatic Fibrosis Improvement by APRI, FIB-4, and Shear Wave Elastography in Hepatitis B Patients

(8-110) Quantitative Analysis of Neonatal and Infant Standardized Concentrations Based upon Smart Pump Utilization Data

(8-111) Research Pharmacy Workflow Changes During Transition to an Electronic Health Record with Computerized Physician Order Entry

(8-112) Optimization of Medication Requests Received via Pneumatic Tube in a Tertiary Hospital

(8-113) Delayed High-dose Methotrexate Clearance with Encephalopathy and Acute Kidney Injury in a Pediatric Patient with Acute Lymphoblastic Leukemia Taking Concomitant Dasatinib: A Case Report

(8-114) Implementation of a Pharmacist Led COVID-19 Pre-exposure Prophylaxis Program in a Community Based Health System Ambulatory Oncology Clinic

(8-115) Sequential Continuing Education Programs Increase Confidence and Knowledge of Pharmacists Managing Iron Deficiency Anemia in Patients with Cancer

(8-116) Antithrombin III Utilization Pre- and Post-implementation of a Non-restrictive Hemostatic Protocol

(8-117) Treatment of a Gastrointestinal Bleed with Subcutaneous Octreotide in a Pediatric Patient

(8-118) Evaluating the Effectiveness of a Revised Hypoglycemic Protocol Incorporating Glucose Gel in a Community Hospital

(8-119) Vancomycin Monitoring in Children Using Bayesian Estimation

(8-120) Does Left-lateral Decubitus Posture Affect Theophylline Absorption?: Retrospective, Exploratory Analysis of a Prospective, Randomized, Steady-state Study in Stable Adult Asthmatic/copd Patients

(8-121) Meropenem Dosing Recommendations in Patients Receiving Home Hemodialysis Using Monte Carlo Simulation

(8-122) Bioconjugated nanometals and cancer therapy: a pharmaceutical perspective

(8-123) Comparison of First Order Pharmacokinetic Equation and Bayesian Approach in Estimating Vancomycin AUC in Critically Ill Patients

(8-124) Pharm. D. Experiential Training in Hospitals – a Virtual One-week Training Following COVID19

(8-125) Personality Characteristics and Expressed Career Choices of Third-year Student Pharmacists

(8-126) Interprofessional Relationships in Healthcare

(8-127) Trends in Postgraduate Year 2 Pharmacy Residencies from 2008 to 2022

(8-128) Shifting Comprehensive Mock Residency Interviews to a Fully Remote Format

(8-129) Challenges Faced by Biopharmaceutical Industry Pharmd Fellows and How to Overcome Them

(8-130) Out-of-pocket Costs for Long-acting Injectable and Oral Antipsychotics by Low-income Subsidy Status of Medicare Part D Beneficiaries with Schizophrenia

(8-131) Development of a Unique Approach to Antimicrobial Stewardship at a Stand-alone Inpatient Psychiatric Facility

(8-132) Therapeutic Interchange Cost-savings Initiative: Lisdexamfetamine to Amphetamine/dextroamphetamine ER

(8-133) 20 Years of Pharmacy Practice Research in a Mother-child University Health Center

(8-134) Annual Audit of the Preparation and Administration of Medication by Nursing Professionals in a Quebec University Hospital Center

(8-135) Monitoring Program of Surface Contamination with 11 Antineoplastic Drugs in 124 Canadian Hospitals

(8-136) Development of a Nursing Intervention to Improve HCAHPS Scores in the Medication Domain

(8-137) Implementation of a Patient-centered Discharge Interview Regarding New Medicine Prescribed During Hospitalization at Neurological Ward at Odense University Hospital in Denmark

(8-138) Safety and Quality Assessment of TPN Delivery When Transitioning from In-house Production to an Outsourcing Admixture Pharmacy

(8-139) Impact of System Wide Process Improvement Initiative to Avoid Therapeutic Duplication for As-needed Indications

(8-140) Allopurinol Induced Neutropenia After Durable Left Ventricular Assist Device (LVAD) Implantation in COVID Positive Patient with Acute Kidney Injury on Renal Replacement Therapy. Case Report

(8-142) Improvement in Clinical Outcomes and Access to Care with Pharmacist-led Chronic Care Management Services at a Rural Family Medicine Clinic

(8-143) Bringing M-health to the Oncological Patient: A Pharmacy Hospital Approach

(8-144) Evaluation of Telephonic versus In-person Medication Counseling on Patient Satisfaction

(8-145) Impact of a Clinical Pharmacist in a Mobile Integrated Health / Telemedicine Program for Chronic Obstructive Pulmonary Disease Patients at High Risk for Readmission

(8-146) Injectable Antipsychotic Efficacy in Schizophrenia and Schizoaffective Disorder: A Mixed Treatment Comparison

(8-147) Evaluating the Impact of Gabapentinoid Tolerance, Naivete, on Peri-operative Oxygen Desaturations